Affymax Inc (OTC Pink - No Information:AFFY)

0.09
Delayed Data
As of May 28
 -0.015 / -14.29%
Today’s Change
0.05
Today|||52-Week Range
0.44
-10.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.9M

Company Description

Affymax, Inc. is a biopharmaceutical company that is discovering, developing novel drugs to improve the treatment of serious and often life-threatening conditions. It has developed OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. Affymax was founded on July 20, 2001 and is headquartered in Palo Alto, CA.

Contact Information

Affymax, Inc.
630 5th Avenue
New York New York 10020
P:(650) 812-8700
Investor Relations:

Employees

Shareholders

Individual stakeholders9.93%
Other institutional1.13%
Mutual fund holders0.00%

Top Executives

Jonathan M. CouchmanChairman, President & Chief Executive Officer
Mark G. ThompsonChief Financial Officer & Secretary

To view my watchlist

Not a member yet?

Sign up now for a free account